306 related articles for article (PubMed ID: 8380670)
1. Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome.
Sedarati F; Margolis TP; Stevens JG
Virology; 1993 Feb; 192(2):687-91. PubMed ID: 8380670
[TBL] [Abstract][Full Text] [Related]
2. Neuronal control of herpes simplex virus latency.
Tenser RB; Edris WA; Hay KA
Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
[TBL] [Abstract][Full Text] [Related]
3. Biological and molecular aspects on herpes simplex virus latency.
Lycke E
Scand J Infect Dis Suppl; 1990; 69():113-9. PubMed ID: 2175937
[TBL] [Abstract][Full Text] [Related]
4. Decreased reporter gene expression during latent infection with HSV LAT promoter constructs.
Margolis TP; Bloom DC; Dobson AT; Feldman LT; Stevens JG
Virology; 1993 Dec; 197(2):585-92. PubMed ID: 8249281
[TBL] [Abstract][Full Text] [Related]
5. Altered properties of the herpes simplex virus ICP8 DNA-binding protein in cells infected with ICP27 mutant viruses.
Curtin KD; Knipe DM
Virology; 1993 Sep; 196(1):1-14. PubMed ID: 8395110
[TBL] [Abstract][Full Text] [Related]
6. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes.
Gesser RM; Valyi-Nagy T; Fraser NW
Virology; 1994 May; 200(2):791-5. PubMed ID: 8178461
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Huard J; Goins WF; Glorioso JC
Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
[TBL] [Abstract][Full Text] [Related]
8. An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers.
Block TM; Deshmane S; Masonis J; Maggioncalda J; Valyi-Nagi T; Fraser NW
Virology; 1993 Feb; 192(2):618-30. PubMed ID: 8380666
[TBL] [Abstract][Full Text] [Related]
9. Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia.
Valyi-Nagy T; Deshmane SL; Spivack JG; Steiner I; Ace CI; Preston CM; Fraser NW
J Gen Virol; 1991 Mar; 72 ( Pt 3)():641-9. PubMed ID: 1848599
[TBL] [Abstract][Full Text] [Related]
10. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
[TBL] [Abstract][Full Text] [Related]
11. Regulation of viral and cellular gene expression in sensory neurons.
Latchman DS
Gene Ther; 1994; 1 Suppl 1():S25-7. PubMed ID: 8542388
[TBL] [Abstract][Full Text] [Related]
12. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
Mukerjee R; Kang W; Suri V; Fraser NW
Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
[TBL] [Abstract][Full Text] [Related]
13. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription.
Chen YM; Knipe DM
Virology; 1996 Jul; 221(2):281-90. PubMed ID: 8661438
[TBL] [Abstract][Full Text] [Related]
14. The US 9, 10, 11, and 12 genes of herpes simplex virus type 1 are of no importance for its neurovirulence and latency in mice.
Nishiyama Y; Kurachi R; Daikoku T; Umene K
Virology; 1993 May; 194(1):419-23. PubMed ID: 8386887
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus vectors and gene transfer to brain.
Glorioso JC; Goins WF; Fink DJ; DeLuca NA
Dev Biol Stand; 1994; 82():79-87. PubMed ID: 7958486
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.
Mester JC; Pitha PM; Glorioso JC
Gene Ther; 1995 May; 2(3):187-96. PubMed ID: 7614249
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits.
O'Brien WJ; Tsao LS; Taylor JL
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1847-53. PubMed ID: 9727407
[TBL] [Abstract][Full Text] [Related]
18. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells.
Jean S; LeVan KM; Song B; Levine M; Knipe DM
Virology; 2001 May; 283(2):273-84. PubMed ID: 11336552
[TBL] [Abstract][Full Text] [Related]
20. [Molecular biology of pathogenesis by herpesvirus].
Barrón BL; Vales N
Rev Latinoam Microbiol; 1991; 33(1):77-85. PubMed ID: 1670258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
